TCRT icon

Alaunos Therapeutics

122 hedge funds and large institutions have $356M invested in Alaunos Therapeutics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

0.01% less ownership

Funds ownership: 0.28%0.27% (-0.01%)

5% less capital invested

Capital invested by funds: $376M → $356M (-$19.8M)

47% less call options, than puts

Call options by funds: $4.96M | Put options by funds: $9.29M

Holders
122
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.96M
Puts
$9.29M
Net Calls
Net Calls Change

Top Buyers

1 +$2.81M
2 +$1.98M
3 +$872K
4
Goldman Sachs
Goldman Sachs
New York
+$823K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$764K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$371K
52
$366K
53
$364K
54
$362K
55
$345K
56
$340K
57
$339K
58
$306K
59
$300K
60
$292K
61
$289K
62
$286K
63
$282K
64
$223K
65
$221K
66
$216K
67
$214K
68
$207K
69
$194K
70
$193K
71
$173K
72
$171K
73
$168K
74
$167K
75
$166K